» Articles » PMID: 26291564

Holmium Laser Enucleation of the Prostate Versus Bipolar Resection of the Prostate: A Prospective Randomized Study. "Pros and Cons"

Overview
Journal Urology
Specialty Urology
Date 2015 Aug 21
PMID 26291564
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the safety, efficacy, and applicability of holmium laser enucleation of the prostate (HoLEP) and bipolar transurethral resection of the prostate (TURPb) procedures, whereas the secondary objective is to find out the advantages and disadvantages of each.

Patients And Methods: A prospective randomized study included 120 patients with benign prostatic hyperplasia that required intervention. The patients were randomized in 2 equal groups: group A managed by HoLEP and group B managed by TURPb. The mean age, International Prostate Symptom Score, maximum urine flow, residual urine, operative time, blood loss, resected volume, catheterization time, hospital stay, and costs were compared.

Results: Both groups were comparable regarding the preoperative parameters. The mean operative time was statistically significantly longer in the HoLEP group. The drop in the hemoglobin level was statistically significantly in group B. The mean resected prostatic volume was 61.167 g in the HoLEP group and 58.8 g in the TURPb group. The catheter was removed after 24 hours in 51 and 36 patients in groups A and B, respectively. The International Prostate Symptom Score at 1 and 12 months and the maximum urine flow at 12 months postoperatively were found to be better in the HoLEP group than in the bipolar group, and this difference was found to be statistically significant.

Conclusion: Although the HoLEP technique is associated with a relatively longer operative time, it has proved to be effective in treating large prostates with minimal morbidity, better hemostasis, less blood loss, and better voiding pattern than TURPb after a 12-month follow-up.

Citing Articles

Transurethral resection of the prostate across continents: a meta-analysis evaluating quality of gold standard in the twenty-first century.

Porto J, Bhatia A, Bhat A, Suarez Arbelaez M, Blachman-Braun R, Shah K World J Urol. 2025; 43(1):85.

PMID: 39856398 PMC: 11761131. DOI: 10.1007/s00345-024-05439-7.


Evaluating transurethral resection of the prostate over twenty years: a systematic review and meta-analysis of randomized clinical trials.

Porto J, Bhatia A, Bhat A, Suarez Arbelaez M, Blachman-Braun R, Shah K World J Urol. 2024; 42(1):639.

PMID: 39547977 PMC: 11568034. DOI: 10.1007/s00345-024-05332-3.


Current era HOLEP with MOSES 2.0 technology compared to the gold standard TURP.

Michael J, Xu P, Dean N, Ganesh M, Tsai K, Khondakar N World J Urol. 2024; 42(1):633.

PMID: 39514127 DOI: 10.1007/s00345-024-05309-2.


Prostate Artery Embolization (PAE) with Small Beads for the Treatment of Benign Prostatic Hyperplasia (BPH).

Xhepa G, Sciacqua L, Vanzulli A, Cani A, Ascenti V, Ricoeur A J Pers Med. 2024; 14(6).

PMID: 38929834 PMC: 11205146. DOI: 10.3390/jpm14060613.


Thirty versus 60-Watt thulium laser enucleation of prostate: Toward the development of low-power anatomical enucleation of the prostate.

Omar M, Abdullah M, Moustafa A, Sultan S Urol Ann. 2024; 16(2):129-132.

PMID: 38818432 PMC: 11135353. DOI: 10.4103/ua.ua_159_22.